What does Pharm@dvice do?

Pharm@dvice is a pharmacy in Fexhe-le-Haut-Clocher. Private Limited, started on 8 September 2010, 1 establishment.

What is the address of Pharm@dvice?

The registered office of Pharm@dvice is located at Grand'Route 90, 4347 Fexhe-le-Haut-Clocher.

Is Pharm@dvice still active?

Yes. According to the CBE (31 October 2026) Pharm@dvice is active, legal situation “Normale toestand”, started on 8 September 2010.

Is Pharm@dvice registered on Peppol?

Yes, Pharm@dvice is registered on the Peppol network with ID 0208:0829109874.

What is the enterprise number of Pharm@dvice?

The enterprise number of Pharm@dvice is BE0829109874.

When was Pharm@dvice founded?

Pharm@dvice was founded on 8 September 2010.

Who are the directors of Pharm@dvice?

According to the 2025 annual accounts, the directors of Pharm@dvice are: PVC INVEST SRL.

Is Pharm@dvice a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 September 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pharm@dvice make in 2025?

Pharm@dvice posted a profit after taxes of € 36,750 in financial year 2025.

What is the revenue of Pharm@dvice?

As a small company, Pharm@dvice is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 84,222.

Pharm@dvice (Private Limited) - Fexhe-le-Haut-Clocher

Dossier Pharm@dvice, printed on 1 November 2026 from databakkes.be/en/0829109874/pharm-dvice. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharm@dvice from Fexhe-le-Haut-Clocher, company number BE0829109874, closed financial year 2025 with a result of € 36,750 after tax. For that financial year Pharm@dvice recorded a gross margin of € 84,222 and equity of € 50,797. Compared with financial year 2024, the result moved from € 8,620 to € 36,750. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2026.

What it is worth Growing

€ 50,797

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 36,750

▲ € 28,131 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,900

▼ 80% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,000 paid out

82 % of the profit went to the shareholders, mostly to PVC INVEST (100 % of the shares). That is where the money ends up.

People and assets in 2025

Wage cost

€ 180

▲ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 9,652

▲ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 334,002

▼ 5% vs 2024

€ 38,977 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 140,757

▲ 50% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,081

▲ 72% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 129,104 Gross margin 2022: € 129,104 First fiscal year in the series	€ 83,167 Gross margin 2023: € 83,167 ▼ 36% vs 2022 (€ 129,104) Unfavourable step	€ 61,925 Gross margin 2024: € 61,925 ▼ 26% vs 2023 (€ 83,167) Unfavourable step	€ 84,222 Gross margin 2025: € 84,222 ▲ 36% vs 2024 (€ 61,925) Favourable step	▲ 36%
Profit after taxes	€ 49,482 Profit after taxes 2022: € 49,482 First fiscal year in the series	€ 8,999 Profit after taxes 2023: € 8,999 ▼ 82% vs 2022 (€ 49,482) Unfavourable step	€ 8,620 Profit after taxes 2024: € 8,620 ▼ 4% vs 2023 (€ 8,999) Unfavourable step	€ 36,750 Profit after taxes 2025: € 36,750 ▲ € 28,131 vs 2024 (€ 8,620) Favourable step	▲ € 28,131
Equity	€ 59,428 Equity 2022: € 59,428 First fiscal year in the series	€ 35,427 Equity 2023: € 35,427 ▼ 40% vs 2022 (€ 59,428) Unfavourable step	€ 44,047 Equity 2024: € 44,047 ▲ 24% vs 2023 (€ 35,427) Favourable step	€ 50,797 Equity 2025: € 50,797 ▲ 15% vs 2024 (€ 44,047) Favourable step	▲ 15%
Total debts	€ 495,954 Total debts 2022: € 495,954 First fiscal year in the series	€ 439,306 Total debts 2023: € 439,306 ▼ 11% vs 2022 (€ 495,954) Favourable step	€ 533,137 Total debts 2024: € 533,137 ▲ 21% vs 2023 (€ 439,306) Unfavourable step	€ 520,994 Total debts 2025: € 520,994 ▼ 2% vs 2024 (€ 533,137) Favourable step	▼ 2%
Cash	€ 56,313 Cash 2022: € 56,313 First fiscal year in the series	€ 36,742 Cash 2023: € 36,742 ▼ 35% vs 2022 (€ 56,313) Unfavourable step	€ 53,485 Cash 2024: € 53,485 ▲ 46% vs 2023 (€ 36,742) Favourable step	€ 10,900 Cash 2025: € 10,900 ▼ 80% vs 2024 (€ 53,485) Unfavourable step	▼ 80%
Land & buildings	€ 173,388 Land & buildings 2022: € 173,388 First fiscal year in the series	€ 162,236 Land & buildings 2023: € 162,236 ▼ 6% vs 2022 (€ 173,388) Unchanged	€ 151,084 Land & buildings 2024: € 151,084 ▼ 7% vs 2023 (€ 162,236) Unchanged	€ 139,932 Land & buildings 2025: € 139,932 ▼ 7% vs 2024 (€ 151,084) Unchanged	▼ 7%
Retained profit	€ 47,028 Retained profit 2022: € 47,028 First fiscal year in the series	€ 23,027 Retained profit 2023: € 23,027 ▼ 51% vs 2022 (€ 47,028) Unfavourable step	€ 31,647 Retained profit 2024: € 31,647 ▲ 37% vs 2023 (€ 23,027) Favourable step	€ 38,397 Retained profit 2025: € 38,397 ▲ 21% vs 2024 (€ 31,647) Favourable step	▲ 21%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 33,000 Dividend 2023: € 33,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 33,000) Unchanged	€ 30,000 Dividend 2025: € 30,000 Unchanged (€ 0) Unchanged
Bank debt	€ 375,397 Bank debt 2022: € 375,397 First fiscal year in the series	€ 331,155 Bank debt 2023: € 331,155 ▼ 12% vs 2022 (€ 375,397) Favourable step	€ 351,748 Bank debt 2024: € 351,748 ▲ 6% vs 2023 (€ 331,155) Unfavourable step	€ 334,002 Bank debt 2025: € 334,002 ▼ 5% vs 2024 (€ 351,748) Favourable step	▼ 5%
Balance sheet total	€ 555,382 Balance sheet total 2022: € 555,382 First fiscal year in the series	€ 474,733 Balance sheet total 2023: € 474,733 ▼ 15% vs 2022 (€ 555,382) Unchanged	€ 577,183 Balance sheet total 2024: € 577,183 ▲ 22% vs 2023 (€ 474,733) Unchanged	€ 571,791 Balance sheet total 2025: € 571,791 ▼ 1% vs 2024 (€ 577,183) Unchanged	▼ 1%
Employees (FTE)	0.5 Employees (FTE) 2022: 0.5 First fiscal year in the series	0.5 Employees (FTE) 2023: 0.5 Unchanged (0.5) Unchanged	-	-

Key figures of Pharm@dvice, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharm@dvice?

What happened at Pharm@dvice in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 28, 2026 New annual accounts for financial year 2025: profit of € 36,750 (▲ € 28,131 vs 2024). filed late Source: NBB ↗
Sep 8, 2010 New establishment in Fexhe-le-Haut-Clocher. KBO
Sep 8, 2010 Start of the company according to the CBE. KBO

In short

From € 49,482 profit in 2022 to € 36,750 profit in 2025.

Paid € 17,398 in corporate taxes since 2022.

Best year ever: 2022, with € 49,482 profit.

Paid out € 63,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

PVC INVEST 100%

The stake of PVC INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Pharm@dvice

Behind Pharm@dvice is PVC INVEST SRL. The shares are held by PVC INVEST (100%).

Directors

According to the 2025 annual accounts

PVC INVEST SRL

Director · represented by Philippe VAN WAUWENBERGE

Also active at: PHARMACIES COLSON

Shareholders

PVC INVEST

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Grand'Route 90

4347 Fexhe-le-Haut-Clocher

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

PVC INVEST same network

€ 102,151 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0829.109.874
VAT number: BE 0829.109.874
Registered office: Grand'Route 90, 4347 Fexhe-le-Haut-Clocher
Names & denominations: Pharm@dvice
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 September 2010
Peppol: Active · Active since 4 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗